Vera Therapeutics (VERA) | Stock Overview & Key Data

Vera Therapeutics Inc. | Healthcare

$22.70

-25.89%

| Vera Therapeutics Stock Comparison:

Vera Therapeutics vs Vertex Vera Therapeutics vs Regeneron Vera Therapeutics vs Immunocore Holdings Vera Therapeutics vs Agios Vera Therapeutics vs Amicus Therapeutics Vera Therapeutics vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Vera Therapeutics Performance Comparison

Loading chart data...

Vera Therapeutics

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $20.50 High: $23.14

on June 6, 2025

52 Week Range

Low: $18.53 High: $51.61

on April 9, 2025

on November 13, 2024

All-Time High: $51.61 on November 11, 2024

Key Statistics

Market Cap i $2.0B

EPS i -3.00

P/E Ratio (TTM) i -7.94

Forward P/E i -9.85

P/B Ratio i 3.65

PEG Ratio i -9.85

Div. Yield i 0.00%

ROE i -39.49%

Beta i 1.128

Debt to Equity i 10.18

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i 0.00%

Profit Margin i 0.00%

Returns and Earnings

Return on Assets (TTM) i -23.46%

Return on Equity (TTM) i -39.49%

EBITDA i $-193.1M

Net Income (TTM) i $-175.5M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i N/A

Quarterly Earnings Growth i N/A

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Vera Therapeutics VERA	1.95B Small-cap	19.79%	3.13%	-22.53%	-53.16%	-46.21%	-41.04%	62.26%	97.39%
Vertex VRTX	113.97B Large-cap	1.91%	0.10%	-7.25%	-2.51%	11.03%	-6.74%	76.75%	67.75%
Regeneron REGN	52.15B Large-cap	0.60%	-11.69%	-29.38%	-36.60%	-31.04%	-50.82%	-13.74%	-16.17%
Immunocore Holdings IMCR	1.94B Small-cap	1.78%	32.75%	20.90%	18.18%	24.92%	-10.63%	26.61%	-13.77%
Agios AGIO	1.93B Small-cap	6.98%	21.22%	1.03%	-44.31%	7.82%	-27.89%	85.57%	-27.17%
Amicus Therapeutics FOLD	1.93B Small-cap	1.48%	-0.48%	-31.71%	-36.69%	-33.83%	-38.71%	-26.23%	-43.64%

Ownership & Short Interest

Insider Ownership i 5.16%

Institutional Ownership i 108.89%

Shares Short i 7M

Short Ratio i 6.17

Short % of Shares Outstanding i 12.77%

Average 10-Day Volume i 3M

Average 90-Day Volume i 2M

Vera Therapeutics Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Vera Therapeutics would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is VERA's 52-week high and low?

In the last 52 weeks, Vera Therapeutics reached a high of $51.61 (on November 13, 2024) and a low of $18.53 (on April 9, 2025).

What is the market cap and P/E ratio for VERA?

Curious about Vera Therapeutics's size and valuation? Its market capitalization stands at 1.95B. When it comes to valuation, the P/E ratio (trailing twelve months) is -7.94, and the forward P/E (looking ahead) is -9.85.

Does VERA pay dividends? If so, what's the yield?

As for dividends, Vera Therapeutics isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Vera Therapeutics's main competitors or similar companies to consider before investing?

When looking at Vera Therapeutics, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Vertex VRTX	113.97B	Healthcare	Biotechnology	-6.74%	76.75%
Regeneron REGN	52.15B	Healthcare	Biotechnology	-50.82%	-13.74%
Immunocore Holdings IMCR	1.94B	Healthcare	Biotechnology	-10.63%	26.61%
Agios AGIO	1.93B	Healthcare	Biotechnology	-27.89%	85.57%
Amicus Therapeutics FOLD	1.93B	Healthcare	Biotechnology	-38.71%	-26.23%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Vera Therapeutics Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Vera Therapeutics's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -39.49%, the Debt to Equity ratio from the most recent quarter is 10.18, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for VERA?

Looking at Vera Therapeutics's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.

How much of VERA stock is held by insiders and institutions?

Wondering who owns Vera Therapeutics stock? Company insiders (like executives and directors) hold about 5.16% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 108.89%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.